rs61742088
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000356392.9(ODAD3):āc.145A>Cā(p.Thr49Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0049 in 1,614,098 control chromosomes in the GnomAD database, including 338 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
ENST00000356392.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ODAD3 | NM_145045.5 | c.145A>C | p.Thr49Pro | missense_variant | 1/13 | ENST00000356392.9 | NP_659482.3 | |
ODAD3 | NM_001302454.2 | c.145A>C | p.Thr49Pro | missense_variant | 1/11 | NP_001289383.1 | ||
ODAD3 | XM_017026241.2 | c.145A>C | p.Thr49Pro | missense_variant | 1/9 | XP_016881730.1 | ||
ODAD3 | NM_001302453.1 | c.82+818A>C | intron_variant | NP_001289382.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ODAD3 | ENST00000356392.9 | c.145A>C | p.Thr49Pro | missense_variant | 1/13 | 1 | NM_145045.5 | ENSP00000348757 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0251 AC: 3824AN: 152122Hom.: 148 Cov.: 33
GnomAD3 exomes AF: 0.00646 AC: 1611AN: 249490Hom.: 72 AF XY: 0.00493 AC XY: 668AN XY: 135372
GnomAD4 exome AF: 0.00278 AC: 4070AN: 1461856Hom.: 188 Cov.: 31 AF XY: 0.00243 AC XY: 1770AN XY: 727224
GnomAD4 genome AF: 0.0252 AC: 3844AN: 152242Hom.: 150 Cov.: 33 AF XY: 0.0240 AC XY: 1789AN XY: 74452
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2018 | - - |
Primary ciliary dyskinesia 30 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at